It has been reported that CD248 expression is substantially increased on tumor stroma in diverse cancers involving lung carcinoma, breast cancer, hepatocellular carcinoma, melanoma, and so on (Lu T. et al., 2023; Yang et al., 2020; Hong et al., 2022; D'Angelo et al., 2018). Here, CD248 is linked to lung carcinoma.